452 related articles for article (PubMed ID: 32954953)
1. Impairment of nuclear F-actin formation and its relevance to cellular phenotypes in Hutchinson-Gilford progeria syndrome.
Takahashi Y; Hiratsuka S; Machida N; Takahashi D; Matsushita J; Hozak P; Misteli T; Miyamoto K; Harata M
Nucleus; 2020 Dec; 11(1):250-263. PubMed ID: 32954953
[TBL] [Abstract][Full Text] [Related]
2. Hutchinson-Gilford progeria syndrome through the lens of transcription.
Prokocimer M; Barkan R; Gruenbaum Y
Aging Cell; 2013 Aug; 12(4):533-43. PubMed ID: 23496208
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome.
Capell BC; Erdos MR; Madigan JP; Fiordalisi JJ; Varga R; Conneely KN; Gordon LB; Der CJ; Cox AD; Collins FS
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12879-84. PubMed ID: 16129833
[TBL] [Abstract][Full Text] [Related]
4. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition.
Glynn MW; Glover TW
Hum Mol Genet; 2005 Oct; 14(20):2959-69. PubMed ID: 16126733
[TBL] [Abstract][Full Text] [Related]
5. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome.
Finley J
Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptor signaling improves Hutchinson-Gilford progeria syndrome cellular phenotypes.
Kreienkamp R; Croke M; Neumann MA; Bedia-Diaz G; Graziano S; Dusso A; Dorsett D; Carlberg C; Gonzalo S
Oncotarget; 2016 May; 7(21):30018-31. PubMed ID: 27145372
[TBL] [Abstract][Full Text] [Related]
7. Progerin impairs chromosome maintenance by depleting CENP-F from metaphase kinetochores in Hutchinson-Gilford progeria fibroblasts.
Eisch V; Lu X; Gabriel D; Djabali K
Oncotarget; 2016 Apr; 7(17):24700-18. PubMed ID: 27015553
[TBL] [Abstract][Full Text] [Related]
8. Molecular insights into the premature aging disease progeria.
Vidak S; Foisner R
Histochem Cell Biol; 2016 Apr; 145(4):401-17. PubMed ID: 26847180
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of Progerin Affects the Symmetry of Cell Division and Is Associated with Impaired Wnt Signaling and the Mislocalization of Nuclear Envelope Proteins.
Sola-Carvajal A; Revêchon G; Helgadottir HT; Whisenant D; Hagblom R; Döhla J; Katajisto P; Brodin D; Fagerström-Billai F; Viceconte N; Eriksson M
J Invest Dermatol; 2019 Nov; 139(11):2272-2280.e12. PubMed ID: 31128203
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic involvement in Hutchinson-Gilford progeria syndrome: a mini-review.
Arancio W; Pizzolanti G; Genovese SI; Pitrone M; Giordano C
Gerontology; 2014; 60(3):197-203. PubMed ID: 24603298
[TBL] [Abstract][Full Text] [Related]
11. Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody.
McClintock D; Gordon LB; Djabali K
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2154-9. PubMed ID: 16461887
[TBL] [Abstract][Full Text] [Related]
12. Imbalanced nucleocytoskeletal connections create common polarity defects in progeria and physiological aging.
Chang W; Wang Y; Luxton GWG; Östlund C; Worman HJ; Gundersen GG
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3578-3583. PubMed ID: 30808750
[TBL] [Abstract][Full Text] [Related]
13. Towards delineating the chain of events that cause premature senescence in the accelerated aging syndrome Hutchinson-Gilford progeria (HGPS).
Dreesen O
Biochem Soc Trans; 2020 Jun; 48(3):981-991. PubMed ID: 32539085
[TBL] [Abstract][Full Text] [Related]
14. Hutchinson-Gilford Progeria Syndrome: Challenges at Bench and Bedside.
Kreienkamp R; Gonzalo S
Subcell Biochem; 2019; 91():435-451. PubMed ID: 30888661
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome.
Goldman RD; Shumaker DK; Erdos MR; Eriksson M; Goldman AE; Gordon LB; Gruenbaum Y; Khuon S; Mendez M; Varga R; Collins FS
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):8963-8. PubMed ID: 15184648
[TBL] [Abstract][Full Text] [Related]
16. Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug treatment.
Columbaro M; Capanni C; Mattioli E; Novelli G; Parnaik VK; Squarzoni S; Maraldi NM; Lattanzi G
Cell Mol Life Sci; 2005 Nov; 62(22):2669-78. PubMed ID: 16261260
[TBL] [Abstract][Full Text] [Related]
17. Towards a Drosophila model of Hutchinson-Gilford progeria syndrome.
Beard GS; Bridger JM; Kill IR; Tree DR
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1389-92. PubMed ID: 19021561
[TBL] [Abstract][Full Text] [Related]
18. All-trans retinoic acid and rapamycin normalize Hutchinson Gilford progeria fibroblast phenotype.
Pellegrini C; Columbaro M; Capanni C; D'Apice MR; Cavallo C; Murdocca M; Lattanzi G; Squarzoni S
Oncotarget; 2015 Oct; 6(30):29914-28. PubMed ID: 26359359
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular Progerin Suppression and Lamin A Restoration Rescue Hutchinson-Gilford Progeria Syndrome.
Sánchez-López A; Espinós-Estévez C; González-Gómez C; Gonzalo P; Andrés-Manzano MJ; Fanjul V; Riquelme-Borja R; Hamczyk MR; Macías Á; Del Campo L; Camafeita E; Vázquez J; Barkaway A; Rolas L; Nourshargh S; Dorado B; Benedicto I; Andrés V
Circulation; 2021 Nov; 144(22):1777-1794. PubMed ID: 34694158
[TBL] [Abstract][Full Text] [Related]
20. Emerging candidate treatment strategies for Hutchinson-Gilford progeria syndrome.
Strandgren C; Revêchon G; Sola-Carvajal A; Eriksson M
Biochem Soc Trans; 2017 Dec; 45(6):1279-1293. PubMed ID: 29127216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
